Gut microbiome-mediated mechanisms of per- and polyfluoroalkyl substances (PFAS) biotransformation and their implications for human health

Per- and polyfluoroalkyl substances (PFAS) represent a diverse group of synthetic chemicals widely utilized in industrial processes, consumer goods, food-contact materials, and plastics due to their exceptional chemical stability and resistance to degradation. However, their pervasive presence in the environment, persistence, and ability to bioaccumulate have raised increasing concerns about human exposure and associated health risks. Dietary intake, through contaminated food, drinking water, and food packaging materials, serves as a primary route of exposure, placing the gastrointestinal tract at the center of PFAS–host interactions. Recent research suggests that the gut microbiome plays a significant role in modifying PFAS toxicokinetics, bioavailability, and biological effects. This review consolidates current insights into the complex relationship between PFAS and the gut microbiome, detailing mechanisms such as microbial uptake, bioaccumulation, enzymatic defluorination, β-oxidation-like biotransformation processes, and alterations in bile acid and short-chain fatty acid metabolism. Conversely, exposure to PFAS can disrupt microbial diversity, compromise intestinal barrier integrity, and affect various host functions, including immune response, metabolism, liver and kidney health, and neuroendocrine regulation. Experimental studies, data from human cohorts, and findings from multi-omics approaches reveal that microbiome-driven changes contribute to chronic health issues like inflammation, metabolic disorders, insulin resistance, and immune system dysregulation. Additionally, advancements in metagenomics, metabolomics, and transcriptomics are shedding light on the intricate mechanisms underlying PFAS–microbiome interactions. These developments underscore the potential for microbiome-targeted interventions to mitigate the adverse health effects of these enduring environmental pollutants.

Authors

Institutions

Publication Details

Journal
Journal of Plastic Film & Sheeting
Published
2026-06-17
DOI
https://doi.org/10.1177/87560879261462980
Primary Topic
Per- and polyfluoroalkyl substances research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Gut microbiome-mediated mechanisms of per- and polyfluoroalkyl substances (PFAS) biotransformation and their implications for human health

Majid Eslami, Saghar Amirpour, Negar Alibabaei, Seyed Soheil Tabibian et al.
Journal of Plastic Film & Sheeting
Per- and polyfluoroalkyl substances research
article

Gut microbiome-mediated mechanisms of per- and polyfluoroalkyl substances (PFAS) biotransformation and their implications for human health

Majid Eslami, Saghar Amirpour, Negar Alibabaei, Seyed Soheil Tabibian, Samira Sanami
article en

Abstract

Per- and polyfluoroalkyl substances (PFAS) represent a diverse group of synthetic chemicals widely utilized in industrial processes, consumer goods, food-contact materials, and plastics due to their exceptional chemical stability and resistance to degradation. However, their pervasive presence in the environment, persistence, and ability to bioaccumulate have raised increasing concerns about human exposure and associated health risks. Dietary intake, through contaminated food, drinking water, and food packaging materials, serves as a primary route of exposure, placing the gastrointestinal tract at the center of PFAS–host interactions. Recent research suggests that the gut microbiome plays a significant role in modifying PFAS toxicokinetics, bioavailability, and biological effects. This review consolidates current insights into the complex relationship between PFAS and the gut microbiome, detailing mechanisms such as microbial uptake, bioaccumulation, enzymatic defluorination, β-oxidation-like biotransformation processes, and alterations in bile acid and short-chain fatty acid metabolism. Conversely, exposure to PFAS can disrupt microbial diversity, compromise intestinal barrier integrity, and affect various host functions, including immune response, metabolism, liver and kidney health, and neuroendocrine regulation. Experimental studies, data from human cohorts, and findings from multi-omics approaches reveal that microbiome-driven changes contribute to chronic health issues like inflammation, metabolic disorders, insulin resistance, and immune system dysregulation. Additionally, advancements in metagenomics, metabolomics, and transcriptomics are shedding light on the intricate mechanisms underlying PFAS–microbiome interactions. These developments underscore the potential for microbiome-targeted interventions to mitigate the adverse health effects of these enduring environmental pollutants.

Journal of Plastic Film & Sheeting
Semnan University of Medical Sciences (IR), Mazandaran University of Medical Sciences (IR)
Openalex Percentile: Top 11%
Per- and polyfluoroalkyl substances research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.